ACS News Service Weekly PressPac: January 2, 2008

• Amber fossils reveal ancient France was a jungle
• Benzene concentrations in beverages
• Toward solving the mystery of idiosyncratic drug reactions
• Toward preventing the warping and splitting of wood
• Discovery of enzyme’s structure may lead to new treatments for celiac disease

Research on a treasure trove of amber has yielded evidence that France once was covered by a dense tropical rainforest with trees similar to those found in the modern-day Amazon. The report on 55-million-year-old pieces of amber from the Oise River area in northern France is scheduled for the Jan. 4 issue of ACS’ Journal of Organic Chemistry, a biweekly publication.

In the new study, Akino Jossang and colleagues used laboratory instruments to analyze the fossilized tree sap in an effort to link specific samples of amber to specific kinds of trees. The amber remained intact over the ages, while the trees from which it oozed disappeared. Efforts to make such connections have been difficult because amber from different sites tended to have very similar chemical compositions. The report describes discovery of a new organic compound in amber called “quesnoin,” whose precursor exists only in sap produced by a tree currently growing only in Brazil’s Amazon rainforest.

Researchers say that amber probably seeped out of a similar tree growing in a tropical forest that covered France millions of years ago before Earth’s continents drifted into their current positions. “The region corresponding to modern France could have been found in a geographically critical marshy zone belonging to Africa and a tropical zone 55 million years ago extending through North Africa to the Amazon,” the report states. — AD

Back to Top

A mysterious and unpredictable group of side effects from modern medications called idiosyncratic drug reactions (IDRs) likely will persist as a major health care problem unless there is a dramatic increase in research funding, according to a 20-year review of research in the field scheduled for the January issue of ACS’ Chemical Research in Toxicology, a monthly journal.

The review, by Jack Uetrecht, defines IDRs as reactions that happen unexpectedly and with no obvious connection to the known effects of a medication’s ingredients or dosage. Although relatively rare, IDRs make an important contribution to the annual burden of death, illness, and increased health care costs from serious adverse drug reactions. In addition, serious IDRs that appear after a new drug has gone into wide use can force drug companies to withdraw products after R&D investments totaling hundreds of millions of dollars.

Two decades of research have produced significant progress, the report acknowledges. However, medical science still has only a “superficial” understanding of how and why IDRs occur and a growing recognition that the mechanisms behind IDRs may be as complicated as those involved in cancer or diabetes. The review describes a need for increased research funding, with more scientists focusing on IDRs, in order to achieve faster progress. — JS

Back to Top

Researchers have discovered a new structure for a key enzyme associated with celiac disease, a finding that could lead to the design of new medications for the common digestive disorder, according to an article scheduled for the Jan. 7 issue of Chemical & Engineering News, ACS’ weekly newsmagazine.

Celiac disease is a condition in which the stomach cannot properly digest wheat and other gluten-containing foods. The disease afflicts an estimated 2 million people in the United States alone.

In the article, C&EN Deputy Assistant Managing Editor Stu Borman notes that the disease is believed to occur when the protein gluten interacts with an enzyme called transglutaminase 2 (TG2), triggering an autoimmune reaction that damages the small intestine and causes diarrhea, abdominal pain and other symptoms. As a result, people with the disease are urged to follow a strict gluten-free diet.

Although scientists have previously obtained the X-ray crystal structure of human TG2, they have only revealed its “closed” or inactive form, the article points out. Now, Chaitan Khosla and colleagues at Stanford University report the first-ever determination of the “open” structure of the enzyme, in which its active site is accessible to substrates. The finding could help scientists design inhibitors of the enzyme that could serve as medications for celiac disease and other related conditions, according to the article.

Back to Top

• Bytesize Science, a podcast for young listeners The American Chemical Society (ACS) Office of Communications has launched Bytesize Science, an educational, entertaining podcast for young listeners. Bytesize Science translates cutting-edge scientific discoveries from ACS' 36 peer-reviewed journals into stories for young listeners about science, health, medicine, energy, food, and other topics. New installments of Bytesize Science are posted every Monday and available without charge. Bytesize Science is now listed as a “new and notable” podcast on iTunes. It is also being recommended by “Podcasting in Education,” an organization that encourages educators to embrace podcasts as a classroom tool. The archive includes items on environmental threats to killer whales, a scientific explanation for why some people love chocolate, the possible medical uses of an intriguing substance known as “dragon’s blood,” and a hairy tale about "hairy roots." The podcaster for Bytesize Science is Adam Dylewski, an ACS science writer and recent graduate of the University of Wisconsin-Madison with degrees in genetics and science communication.
• to Bytesize Science in iTunes
• iTunes? No problem. Listen to latest episodes of Bytesize Science in your web browser
• Science Elements: An ACS Science News Podcast
  The ACS Office of Communications is podcasting PressPac contents in order to make cutting-edge scientific discoveries from ACS journals available to a broad public audience at no charge. Science Elements includes selected content from ACS’s prestigious suite of 36 peer-reviewed scientific journals and Chemical & Engineering News, ACS’s weekly news magazine. Those journals, published by the world’s largest scientific society, contain about 30,000 scientific reports from scientists around the world each year. The reports include discoveries in medicine, health, nutrition, energy, the environment and other fields that span science’s horizons from astronomy to zoology. Podcaster for Science Elements is Steve Showalter, Ph.D., a chemist at the U. S. Department of Energy’s Sandia National Laboratories in Albuquerque, New Mexico, and ACS member.

• Highlights, resources from ACS Chocolate Workshop now online
• American Chemical Society’s workshop, 'Cooks with Chemistry —The Elements of Chocolate' provided reporters with a delectable assortment of new information on the world’s favorite treat. Held Oct. 11, 2007, at the Institute of Culinary Education in New York City and sponsored by the ACS Office of Communications, the chocolate workshop featured presentations from Harold McGee and Shirley Corriher, award-winning cookbook authors, and Sara Risch, the noted food and flavor chemist. With chocolate consumption nearing an annual peak as the holidays approach, we are providing content from this event to news media unable to attend the workshop. The material includes ACS journal articles about the chemistry of chocolate; advice for cooks who run into trouble with chocolate recipes; tips on how to successfully use “new” chocolates in old favorite recipes; and a fascinating comparison of the health benefits and flavor components of different kinds of chocolate. For interviews with the chocolate workshop participants or other information, please contact newsroom@acs.org.
• ACS Press releases
  A treasure trove of news ideas, background material, news sources, and other information issued by the ACS Office of Communications.
• General Chemistry Glossary
• PressPac Archives
• More ACS News
  
  
  
  

Back to Top